• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性肾上腺皮质增生症的遗传学。

Genetics of Congenital Adrenal Hyperplasia.

机构信息

Section on Endocrinology and Genetics, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1-2740, 10 Center Drive, MSC 1932, Bethesda, MD 20892-1932, USA.

Clinical DNA Testing and DNA Banking, PreventionGenetics, 3800 South Business Park Avenue, Marshfield, WI 54449, USA.

出版信息

Endocrinol Metab Clin North Am. 2017 Jun;46(2):435-458. doi: 10.1016/j.ecl.2017.01.008. Epub 2017 Mar 1.

DOI:10.1016/j.ecl.2017.01.008
PMID:28476231
Abstract

Congenital adrenal hyperplasia (CAH) refers to a group of autosomal recessive disorders due to single-gene defects in the various enzymes required for cortisol biosynthesis. CAH represents a continuous phenotypic spectrum with more than 95% of all cases caused by 21-hydroxylase deficiency. Genotyping is an important tool in confirming the diagnosis or carrier state, provides prognostic information on disease severity, and is essential for genetic counseling. In this article, the authors provide an in-depth discussion on the genetics of CAH, including genetic diagnosis, molecular analysis, genotype-phenotype relationships, and counseling of patients and their families.

摘要

先天性肾上腺皮质增生症(CAH)是一组常染色体隐性遗传疾病,由皮质醇生物合成所需的各种酶的单个基因缺陷引起。CAH 代表了一个连续的表型谱,超过 95%的病例是由于 21-羟化酶缺乏引起的。基因分型是确认诊断或携带者状态的重要工具,提供疾病严重程度的预后信息,对遗传咨询至关重要。本文作者深入讨论了 CAH 的遗传学,包括遗传诊断、分子分析、基因型-表型关系,以及患者及其家属的咨询。

相似文献

1
Genetics of Congenital Adrenal Hyperplasia.先天性肾上腺皮质增生症的遗传学。
Endocrinol Metab Clin North Am. 2017 Jun;46(2):435-458. doi: 10.1016/j.ecl.2017.01.008. Epub 2017 Mar 1.
2
Congenital Adrenal Hyperplasia.先天性肾上腺皮质增生症
Exp Suppl. 2019;111:245-260. doi: 10.1007/978-3-030-25905-1_12.
3
Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.先天性肾上腺皮质增生症(CAH)由于 21-羟化酶缺乏症:对 CYP21A2 基因的 233 种致病性变异的全面关注。
Mol Diagn Ther. 2018 Jun;22(3):261-280. doi: 10.1007/s40291-018-0319-y.
4
An update to 21-hydroxylase deficient congenital adrenal hyperplasia.21-羟化酶缺陷型先天性肾上腺皮质增生症的更新。
Gynecol Endocrinol. 2010 Jan;26(1):63-71. doi: 10.3109/09513590903015494.
5
Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.先天性肾上腺皮质增生症中的类固醇21-羟化酶缺乏症。
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):2-11. doi: 10.1016/j.jsbmb.2016.06.015. Epub 2016 Jul 2.
6
[Adrenogenital syndrome--molecular biology and prenatal diagnosis].
Ugeskr Laeger. 1998 Feb 2;160(6):803-7.
7
21-hydroxylase deficiency congenital adrenal hyperplasia.21-羟化酶缺乏症先天性肾上腺皮质增生症
J Steroid Biochem Mol Biol. 1994 Jan;48(1):15-22. doi: 10.1016/0960-0760(94)90246-1.
8
Congenital adrenal hyperplasia: diagnostic advances.先天性肾上腺皮质增生症:诊断进展
J Inherit Metab Dis. 2007 Aug;30(4):563-75. doi: 10.1007/s10545-007-0696-6. Epub 2007 Aug 10.
9
Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods.先天性肾上腺增生症:临床症状与诊断方法。
Acta Biochim Pol. 2018;65(1):25-33. doi: 10.18388/abp.2017_2343. Epub 2018 Mar 15.
10
Impact of molecular genetics on congenital adrenal hyperplasia management.分子遗传学对先天性肾上腺皮质增生症管理的影响。
Sex Dev. 2010 Sep;4(4-5):233-48. doi: 10.1159/000315959. Epub 2010 Jul 15.

引用本文的文献

1
Clinical outcomes and treatment adequacy assessment in congenital adrenal hyperplasia: A Single-Center experience with Long-Term Follow-Up.先天性肾上腺皮质增生症的临床结局与治疗充分性评估:单中心长期随访经验
Endocrine. 2025 Sep 3. doi: 10.1007/s12020-025-04411-8.
2
Longitudinal 12-Month Follow-Up of a Male Infant with Compound Heterozygous Genotype in China: A Case Report.中国一名具有复合杂合基因型男婴的12个月纵向随访:病例报告
AJP Rep. 2025 Jul 18;15(3):e116-e123. doi: 10.1055/a-2647-4369. eCollection 2025 Jul.
3
Genotype-Phenotype Correlation in Children With Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Using Next Generation Sequencing.
使用下一代测序技术对21-羟化酶缺乏所致先天性肾上腺皮质增生症患儿的基因型-表型相关性研究
Mol Genet Genomic Med. 2025 Jun;13(6):e70110. doi: 10.1002/mgg3.70110.
4
From Severe Virilization to Precocious Puberty in a 46,XX Patient: Therapeutic Challenges in a Case of 11β-Hydroxylase Deficiency.一名46,XX患者从严重男性化到性早熟:11β-羟化酶缺乏症病例的治疗挑战
Cureus. 2025 May 12;17(5):e83965. doi: 10.7759/cureus.83965. eCollection 2025 May.
5
Single cell resolution of neurosteroidogenesis in the murine brain: intermediary biosynthesis.小鼠大脑中神经甾体生成的单细胞分辨率:中间生物合成
J Endocrinol. 2025 May 7;265(3). doi: 10.1530/JOE-24-0333. Print 2025 Jun 1.
6
Assessment of Long-Read Sequencing-Based Congenital Adrenal Hyperplasia Genotyping Assay for Newborns in Fujian, China.基于长读长测序的中国福建新生儿先天性肾上腺皮质增生症基因分型检测评估
Int J Neonatal Screen. 2025 Mar 13;11(1):22. doi: 10.3390/ijns11010022.
7
Barriers to the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.21-羟化酶缺乏所致经典型先天性肾上腺皮质增生症管理中的障碍
J Clin Endocrinol Metab. 2025 Jan 21;110(Supplement_1):S67-S73. doi: 10.1210/clinem/dgae710.
8
Comparison of long-read sequencing and MLPA combined with long-PCR sequencing of mutations in patients with 21-OHD.21-羟化酶缺乏症患者突变的长读长测序与MLPA联合长PCR测序的比较
Front Genet. 2024 Nov 1;15:1472516. doi: 10.3389/fgene.2024.1472516. eCollection 2024.
9
46,XX males with congenital adrenal hyperplasia: a clinical and biochemical description.46,XX 男性先天性肾上腺皮质增生症:临床和生化描述。
Front Endocrinol (Lausanne). 2024 Aug 8;15:1410122. doi: 10.3389/fendo.2024.1410122. eCollection 2024.
10
Cytogenomic description of a Mexican cohort with differences in sex development.对墨西哥一个性发育存在差异的队列进行的细胞基因组描述。
Mol Cytogenet. 2024 Jul 15;17(1):16. doi: 10.1186/s13039-024-00685-1.